CVS Health ROE 2010-2024 | CVS

Current and historical return on equity (ROE) values for CVS Health (CVS) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
CVS Health ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2024-12-31 $4.61B $75.73B 6.15%
2024-09-30 $5.02B $75.11B 6.67%
2024-06-30 $7.19B $75.11B 9.57%
2024-03-31 $7.32B $74.15B 9.82%
2023-12-31 $8.34B $76.64B 11.29%
2023-09-30 $8.63B $74.51B 11.87%
2023-06-30 $2.97B $73.00B 4.13%
2023-03-31 $4.09B $71.58B 5.65%
2022-12-31 $4.31B $71.77B 5.90%
2022-09-30 $3.37B $71.01B 4.56%
2022-06-30 $8.38B $75.51B 11.18%
2022-03-31 $8.13B $74.14B 10.93%
2021-12-31 $8.00B $75.38B 10.86%
2021-09-30 $7.58B $74.62B 10.49%
2021-06-30 $7.20B $73.57B 10.16%
2021-03-31 $7.40B $71.16B 10.63%
2020-12-31 $7.18B $69.70B 10.53%
2020-09-30 $7.95B $69.11B 11.91%
2020-06-30 $8.26B $68.36B 12.66%
2020-03-31 $7.22B $65.47B 11.36%
2019-12-31 $6.63B $64.17B 10.67%
2019-09-30 $4.47B $62.93B 7.35%
2019-06-30 $4.33B $61.60B 7.99%
2019-03-31 $-0.17B $60.01B -0.36%
2018-12-31 $-0.59B $58.54B -1.40%
2018-09-30 $3.11B $36.62B 8.38%
2018-06-30 $3.01B $35.61B 8.19%
2018-03-31 $6.67B $38.68B 18.35%
2017-12-31 $6.62B $37.70B 18.85%
2017-09-30 $5.04B $34.87B 14.44%
2017-06-30 $5.30B $34.15B 15.05%
2017-03-31 $5.12B $33.84B 14.49%
2016-12-31 $5.32B $36.83B 14.81%
2016-09-30 $5.11B $35.95B 14.19%
2016-06-30 $4.81B $34.77B 13.26%
2016-03-31 $5.16B $36.03B 13.99%
2015-12-31 $5.24B $37.20B 14.11%
2015-09-30 $5.06B $37.18B 13.56%
2015-06-30 $4.76B $37.13B 12.68%
2015-03-31 $4.74B $37.00B 12.53%
2014-12-31 $4.64B $37.96B 12.19%
2014-09-30 $4.59B $38.11B 12.04%
2014-06-30 $4.89B $38.13B 12.80%
2014-03-31 $4.77B $38.21B 12.41%
2013-12-31 $4.59B $37.94B 11.96%
2013-09-30 $4.44B $38.53B 11.59%
2013-06-30 $4.20B $38.91B 11.08%
2013-03-31 $4.04B $38.21B 10.73%
2012-12-31 $3.86B $37.65B 10.27%
2012-09-30 $3.81B $36.92B 10.11%
2012-06-30 $3.68B $37.91B 9.70%
2012-03-31 $3.53B $38.05B 9.29%
2011-12-31 $3.46B $38.05B 9.13%
2011-09-30 $3.42B $37.49B 9.05%
2011-06-30 $3.36B $38.24B 8.94%
2011-03-31 $3.37B $37.92B 9.10%
2010-12-31 $3.43B $37.70B 9.40%
2010-09-30 $3.45B $36.64B 9.59%
2010-06-30 $3.66B $35.87B 10.25%
2010-03-31 $3.73B $35.69B 10.41%
2009-12-31 $3.70B $35.77B 10.35%
Sector Industry Market Cap Revenue
Medical Medical Services $79.102B $372.809B
CVS Health Corporation is a pharmacy innovation company. Its offerings include pharmacy benefit management services, mail order, retail and specialty pharmacy, disease management programs, and retail clinics. The Company serves employers, insurance companies, unions, government employee groups, managed care organizations and other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS/pharmacy, RxAmerica, Accordant, SilverScript, and Novologix names. CVS Health Corporation, formerly known as CVS Caremark Corporation, is headquartered in Woonsocket, Rhode Island.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $140.350B 26.32
Elevance Health (ELV) United States $91.117B 11.76
Cencora (COR) United States $56.251B 19.57
DiDi Global (DIDIY) China $21.979B 33.36
Natera (NTRA) United States $20.836B 0.00
BioMerieux (BMXMF) France $15.355B 0.00
Solventum (SOLV) United States $12.822B 13.57
EUROFINS SCIENT (ERFSF) Luxembourg $12.604B 0.00
CochLear (CHEOY) Australia $11.282B 0.00
Revvity (RVTY) United States $10.993B 18.92
ICON (ICLR) Ireland $10.630B 9.88
Viatris (VTRS) United States $10.375B 3.56
Doximity (DOCS) United States $9.813B 45.70
Avantor (AVTR) United States $9.138B 13.28
Medpace Holdings (MEDP) United States $8.785B 23.33
HealthEquity (HQY) United States $8.497B 41.80
Sonic Healthcare (SKHHY) Australia $8.220B 0.00
Charles River Laboratories (CRL) United States $6.924B 13.57
Amplifon S.p.A (AMFPF) Italy $4.966B 26.21
BrightSpring Health Services (BTSG) United States $4.257B 39.40
Bausch + Lomb (BLCO) Canada $4.156B 24.50
Sotera Health (SHC) United States $3.633B 20.65
Alignment Healthcare (ALHC) United States $3.122B 0.00
Surgery Partners (SGRY) United States $3.068B 39.90
Concentras Parent (CON) United States $2.912B 16.83
Organon (OGN) United States $2.350B 2.50
Ardent Health Partners (ARDT) United States $2.204B 9.40
GeneDx Holdings (WGS) United States $1.949B 75.07
Progyny (PGNY) United States $1.912B 42.08
Premier (PINC) United States $1.904B 14.45
PACS (PACS) United States $1.647B 0.00
GoodRx Holdings (GDRX) United States $1.414B 28.29
Teladoc Health (TDOC) United States $1.319B 0.00
Pediatrix Medical (MD) United States $1.283B 9.76
Establishment Labs Holdings (ESTA) $1.046B 0.00
Agilon Health (AGL) United States $1.014B 0.00
Ryman Healthcare (RYHTY) New Zealand $0.998B 0.00
CareDx (CDNA) United States $0.977B 15.25
Nutex Health (NUTX) United States $0.972B 14.69
AMN Healthcare Services Inc (AMN) United States $0.869B 8.13
QDM (QDMI) Hong Kong, SAR China $0.729B 0.00
Embecta (EMBC) United States $0.702B 4.73
InnovAge Holding (INNV) United States $0.566B 0.00
Enhabit (EHAB) United States $0.539B 44.33
Auna S.A (AUNA) Luxembourg $0.514B 13.63
Sonida Senior Living (SNDA) United States $0.494B 0.00
LifeMD (LFMD) United States $0.487B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.370B 0.00
SBC Medicals (SBC) United States $0.352B 0.00
Oncology Institute (TOI) United States $0.226B 0.00
Beauty Health (SKIN) United States $0.218B 0.00
Performant Healthcare (PHLT) United States $0.209B 0.00
DocGo (DCGO) United States $0.150B 24.50
Sera Prognostics (SERA) United States $0.087B 0.00
So-Young (SY) China $0.084B 0.00
OncoCyte (OCX) United States $0.080B 0.00
KindlyMD (KDLY) United States $0.078B 0.00
Ascend Wellness Holdings (AAWH) United States $0.065B 0.00
NeueHealth (NEUE) United States $0.062B 0.00
IceCure Medical (ICCM) Israel $0.058B 0.00
Biodesix (BDSX) United States $0.044B 0.00
Basel Medical Group (BMGL) Singapore $0.044B 0.00
Pheton Holdings (PTHL) China $0.036B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.033B 0.00
ModivCare (MODV) United States $0.013B 0.00
SeaStar Medical Holding (ICU) United States $0.013B 0.00
Co-Diagnostics (CODX) United States $0.010B 0.00
Intelligent Bio Solutions (INBS) United States $0.008B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
XWELL (XWEL) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
INVO Fertility (IVF) United States $0.002B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Cano Health (CANOQ) United States $0.000B 0.00